Rhabdomyolysis reports show interaction between simvastatin and CYP3A4 inhibitors.
about
Benefits & risks of statin therapy for primary prevention of cardiovascular disease in Asian Indians - a population with the highest risk of premature coronary artery disease & diabetesThe clinical pharmacogenomics implementation consortium: CPIC guideline for SLCO1B1 and simvastatin-induced myopathy.The effect of simvastatin on inflammatory cytokines in community-acquired pneumonia: a randomised, double-blind, placebo-controlled trial.Drug-related myopathies of which the clinician should be awareCo-medication of statins with contraindicated drugs.Individual and Combined Associations of Genetic Variants in CYP3A4, CYP3A5, and SLCO1B1 With Simvastatin and Simvastatin Acid Plasma ConcentrationsIndividualized risk for statin-induced myopathy: current knowledge, emerging challenges and potential solutionsA population-based analysis of the risk of drug interaction between clarithromycin and statins for hospitalisation or death.Assessment of statin-associated muscle toxicity in Japan: a cohort study conducted using claims database and laboratory information.A screening study of drug-drug interactions in cerivastatin users: an adverse effect of clopidogrelClinical importance of the drug interaction between statins and CYP3A4 inhibitors: a retrospective cohort study in The Health Improvement Network.Update on toxic myopathies.Pravastatin-induced rhabdomyolysis and purpura fulminans in a patient with chronic renal failure.Rhabdomyolysis caused by an unusual interaction between azithromycin and simvastatin.Pharmacokinetic interactions between simvastatin and setipiprant, a CRTH2 antagonist.Rhabdomyolysis in association with simvastatin and dosage increment in clarithromycin.Pharmacokinetic interactions of almorexant with midazolam and simvastatin, two CYP3A4 model substrates, in healthy male subjects.Almorexant effects on CYP3A4 activity studied by its simultaneous and time-separated administration with simvastatin and atorvastatin.Effect of posaconazole on the pharmacokinetics of simvastatin and midazolam in healthy volunteers.Onset timing of statin-induced musculoskeletal adverse events and concomitant drug-associated shift in onset timing of MAEs
P2860
Q26853571-F3529128-1CD6-4C22-8ABD-91F3A48D6138Q34276618-55C84926-08EB-430A-9DC9-3ECA59605866Q34903761-FDEAE7B6-688A-44DC-B9BD-5EF30A581339Q34974845-894C93F6-570D-46A8-AC14-B8ED421259ADQ35561151-922DAE9B-3171-4317-96E3-C55E88B86391Q35855012-0CAAA218-BBC3-4171-AE15-73A5ACE7CA3BQ35915932-D0FB6461-0E8B-463D-89B3-D2CA35A0F438Q36203546-33EF6074-2743-4F08-A523-7622FC80D076Q36809811-14B7AD42-7A8F-451E-BE57-FFE1BEF51C26Q37316562-3B1C6122-CF15-4C8C-95EF-58058E3A04A5Q37473382-88E2BD3A-ECEA-45BD-AAB4-224A37572365Q37942033-7AE2940D-FD20-48C3-8A0B-90A271DB8A57Q41871657-27E561F2-D259-47B3-B6CF-E17992FE3365Q42393296-27F78AF3-5F3B-4766-9AB1-D5BCDC83A080Q42688670-46F45BDB-7ACB-4C04-A4EB-696A5EDFE911Q42704777-16E8B35C-D62D-43DC-9C5D-FD10AE998A26Q45749050-F698422D-3902-4ED0-831E-74952D9B6BA1Q46136908-488D11CE-D1DC-4C2D-A269-4C9D90CDBA02Q48202863-4C4115FA-6EDB-477B-A0EB-F1B5A65FC766Q59133164-66D85CA4-047E-4ACD-BB1D-32CE6500F6C0
P2860
Rhabdomyolysis reports show interaction between simvastatin and CYP3A4 inhibitors.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on April 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Rhabdomyolysis reports show interaction between simvastatin and CYP3A4 inhibitors.
@en
Rhabdomyolysis reports show interaction between simvastatin and CYP3A4 inhibitors.
@nl
type
label
Rhabdomyolysis reports show interaction between simvastatin and CYP3A4 inhibitors.
@en
Rhabdomyolysis reports show interaction between simvastatin and CYP3A4 inhibitors.
@nl
prefLabel
Rhabdomyolysis reports show interaction between simvastatin and CYP3A4 inhibitors.
@en
Rhabdomyolysis reports show interaction between simvastatin and CYP3A4 inhibitors.
@nl
P2093
P2860
P356
P1476
Rhabdomyolysis reports show interaction between simvastatin and CYP3A4 inhibitors.
@en
P2093
Allen D Brinker
Andrew Mosholder
Christopher Rowan
Jeffrey S Barrett
Jennie Chang
Mark Avigan
Parivash Nourjah
P2860
P304
P356
10.1002/PDS.1711
P577
2009-04-01T00:00:00Z